CAD 0.49
(4.26%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.03 CAD | 52.92% |
2022 | -0.07 CAD | 73.62% |
2021 | -0.26 CAD | 23.53% |
2020 | -0.34 CAD | 10.53% |
2019 | -0.38 CAD | 57.3% |
2018 | -0.89 CAD | -456.25% |
2017 | -0.16 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.01 CAD | 76.05% |
2024 Q1 | -0.03 CAD | -471.11% |
2023 Q4 | 0.01 CAD | 130.93% |
2023 Q2 | -0.00 CAD | 80.39% |
2023 FY | - CAD | 52.92% |
2023 Q1 | -0.01 CAD | 81.82% |
2023 Q3 | -0.03 CAD | -1355.0% |
2022 Q2 | -0.02 CAD | 17.36% |
2022 Q3 | 0.04 CAD | 264.38% |
2022 FY | - CAD | 73.62% |
2022 Q1 | -0.03 CAD | 6.36% |
2022 Q4 | -0.06 CAD | -255.83% |
2021 FY | - CAD | 23.53% |
2021 Q4 | -0.03 CAD | 58.75% |
2021 Q3 | -0.07 CAD | 25.11% |
2021 Q2 | -0.09 CAD | -18.96% |
2021 Q1 | -0.08 CAD | 0.0% |
2020 Q3 | -0.09 CAD | -116.67% |
2020 Q2 | -0.04 CAD | 54.57% |
2020 FY | - CAD | 10.53% |
2020 Q1 | -0.10 CAD | 0.0% |
2020 Q4 | - CAD | 100.0% |
2019 FY | - CAD | 57.3% |
2019 Q4 | - CAD | 100.0% |
2019 Q3 | -0.12 CAD | -27.8% |
2019 Q2 | -0.09 CAD | -51.94% |
2019 Q1 | -0.06 CAD | 0.0% |
2018 Q4 | - CAD | 100.0% |
2018 FY | - CAD | -456.25% |
2018 Q1 | -0.07 CAD | 0.0% |
2018 Q2 | -0.49 CAD | -601.0% |
2018 Q3 | -0.10 CAD | 80.57% |
2017 FY | - CAD | 0.0% |
2017 Q4 | - CAD | 100.0% |
2017 Q3 | -0.03 CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | -0.02 CAD | -44.196% |
CanadaBis Capital Inc. | 0.03 CAD | 199.691% |
Decibel Cannabis Company Inc. | -0.00 CAD | -651.163% |
Delivra Health Brands Inc. | 0.00 CAD | 1141.935% |
Entourage Health Corp. | -0.15 CAD | 78.467% |
Lifeist Wellness Inc. | -0.58 CAD | 94.431% |
Cannara Biotech Inc. | 0.08 CAD | 141.517% |
Medicure Inc. | -0.09 CAD | 63.42% |
PharmaCielo Ltd. | -0.10 CAD | 67.7% |
BioSyent Inc. | 0.54 CAD | 105.981% |
Voyageur Pharmaceuticals Ltd. | -0.01 CAD | -201.869% |